Medpace is rated Sell, with a $484.49 fair value versus a $612.05 close—implying a 26.33% premium. Click to read more about ...
The Mid Cap Value Fund fell 4.77% in the third quarter, trailing the Russell Midcap® Value Index, which was down 1.98%.
For many Ugandan entrepreneurs, the challenge is no longer finding capital, it is proving that their businesses are ready for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results